Cepheid develops, manufactures, and markets industry-leading molecular diagnostic tests and test systems.
These include fast, accurate, and easy to use tests for SARS-CoV-2, the virus causing COVID-19, Flu, MRSA, tuberculosis, and other HAI, sexual health, and oncology diseases. Each test is designed for use on any of the tens of thousands of configurable GeneXpert® Systems placed in hospitals, ER's, clinics, nursing homes, and other settings worldwide.
With more than 20 FDA-cleared tests (including moderate complexity and CLIA waived tests), Cepheid is your partner for empowering clinicians with fast, accurate results. Learn more at www.cepheid.com.
